Physician profile
Michael K Weil
NPI 1780750802
$5,727.46
in general payments reported to CMS, 2019-2025
32 companies · $923 in 2025
The $923 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $678 · 2021: $687 · 2022: $776 · 2023: $839 · 2024: $1,112 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,679 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,679.02 |
| Education | $195.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,534.46 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $502.99 | 2019-2025 | Tremfya |
| Pfizer INC. | $480.35 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $467.21 | 2019-2025 | |
| Genzyme Corporation | $460.39 | 2019-2025 | |
| Amgen INC. | $411.83 | 2019-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $355.21 | 2020-2025 | Dupixent, Libtayo |
| Ucb, INC. | $334.58 | 2019-2025 | Bimzelx |
| Medimetriks Pharmaceuticals, INC. | $131.79 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $119.35 | 2022-2024 | Sotyktu |
| Genentech USA, INC. | $95.75 | 2019-2022 | |
| Leo Pharma INC. | $84.18 | 2022-2025 | Adbry |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Galderma Laboratories, L.P. | $66.64 | 2019-2024 | |
| Incyte Corporation | $56.52 | 2022-2023 | Opzelura |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $55.44 | 2019-2020 | |
| Arcutis Biotherapeutics, INC. | $52.52 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $51.85 | 2022 | |
| Strata Skin Sciences, INC. | $48.84 | 2023-2025 | Xtrac |
| Journey Medical Corporation | $42.59 | 2022-2025 | |
| Verrica Pharmaceuticals INC. | $38.21 | 2023-2025 | Ycanth |
| Almirall LLC | $35.94 | 2020-2025 | Seysara |
| Celgene Corporation | $34.90 | 2019 | |
| Mayne Pharma Commercial LLC | $29.74 | 2023 | |
| Organogenesis INC. | $26.81 | 2025 | Novachor |
| Epi Health, LLC | $26.72 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.32 | 2019-2020 | |
| Lnhc, INC | $18.90 | 2025 | Zelsuvmi |
| Dermavant Sciences, INC. | $17.30 | 2022 | |
| Allergan, INC. | $16.14 | 2020 | |
| Dermira, INC. | $15.04 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.